Pharmacy Department, Consorci Sociosanitari de Vilafranca, Vilafranca del Penedes, Barcelona, Spain
Pharmacy Department, Althaia Foundation of Manresa, Manresa, Catalunya, Spain.
Eur J Hosp Pharm. 2023 Mar;30(e1):e66-e69. doi: 10.1136/ejhpharm-2022-003237. Epub 2022 May 6.
This study analysed whether the Model List of Essential Medicines is suitable for elderly patients. Furthermore, it investigated the specific issues that should be considered when prescribing a drug and which drugs should be added to improve the list according to the explicit criteria guidelines.
A qualitative descriptive review was performed comparing the explicit criteria guidelines of Beers 2019, Laroche, McLeod, NORGEP, PRISCUS, STOPP/START 2014 and Winit-Watjana with the 22nd edition of the Model List of Essential Medicines.
The Model List of Essential Medicines has 458 drugs. Depending on the explicit criteria considered, there were different numbers of potentially inappropriate medications and potential prescribing omissions. When all explicit criteria were combined, a total of 73 medicines were classified as potentially inappropriate. Using the STOPP/START criteria, 46 potential prescribing omissions were detected. According to these explicit criteria, the Model List of Essential Medicines appeared to lack some medicines.
Explicit criteria guidelines have different potential for detecting potentially inappropriate medications. Our findings suggest that some drugs should be added to the next edition of the Model List of Essential Medicines to cover some therapeutic gaps.
本研究分析了《基本药物示范目录》是否适用于老年患者。此外，还根据明确的标准指南，研究了开具药物时应考虑的具体问题，以及应添加哪些药物以改善该目录。
采用定性描述性综述方法，将 2019 年 Beers 标准、Laroche 标准、McLeod 标准、NORGEP 标准、PRISCUS 标准、STOPP/START 2014 标准和第 22 版《基本药物示范目录》的明确标准指南进行比较。
《基本药物示范目录》共有 458 种药物。根据所考虑的明确标准，潜在不适当药物和潜在处方遗漏的数量不同。当综合所有明确标准时，共有 73 种药物被归类为潜在不适当。使用 STOPP/START 标准，发现了 46 种潜在的处方遗漏。根据这些明确标准，《基本药物示范目录》似乎缺乏一些药物。
明确标准指南在检测潜在不适当药物方面具有不同的潜力。我们的研究结果表明，下一个版本的《基本药物示范目录》应添加一些药物，以弥补一些治疗空白。
